No-code frontline operations platform delivering composable electronic batch records with 21 CFR Part 11 compliance, deployable in 90 days with validated apps for pharmaceutical manufacturing.
Tulip Electronic Batch Records is a core component of Tulip's Composable MES for Pharma, a no-code frontline operations platform designed to accelerate digital transformation for pharmaceutical and life sciences manufacturers. The platform enables operations teams to rapidly build, deploy, and modify batch record applications using visual drag-and-drop tools without programming expertise, allowing engineers and process owners to create validated eBR apps directly.
The system delivers 21 CFR Part 11 and Annex 11 compliance out of the box, featuring audit trails, electronic signatures, access control, and secure data handling. Validated using Computer System Assurance (CSA) guidance, Tulip's pharma MES can be implemented in as little as 90 days with pre-built validated apps for logbooks, weigh & dispense, sampling, packaging, and eBR review. Pharmaceutical customers report 75% reduction in time spent reviewing detailed logbooks and 30% faster processes with digital guidance and audit trails.
Key differentiators include human-centric AI capabilities, native connectivity to devices and machines (scales, barcode scanners, sensors), real-time monitoring with automated quality checks, and integration with Quality Management Systems for deviation logging and CAPA tracking. The platform supports deployment across mobile devices, tablets, desktop workstations, and wearables, with multi-language support (28 languages via AI translation) for global manufacturing operations.
Tulip serves pharmaceutical and biotech companies ranging from mid-size manufacturers to large enterprises including GSK and Johnson & Johnson.
Pharmaceutical Edition
Tulip Composable MES for Pharma, announced in January 2025, is a foundational set of applications enabling pharmaceutical companies to rapidly deploy electronic batch records, logbooks, and batch production management solutions in production environments. The pharma-specific edition includes pre-built validated apps for weigh & dispense, sampling, packaging, eBR review, equipment logbooks, line clearance, and operator training compliance. Tulip also announced a partnership with Sequence to develop digital manufacturing solutions eliminating paper-based records.
Core Capabilities
FDA & GxP Compliance
International Standards
Data Integrity & Validation
Tulip is delivered as a cloud-based SaaS frontline operations platform with deployment across Windows, macOS, web browsers, Android, and iOS devices. The architecture features Edge Devices for native connectivity to manufacturing equipment, enabling real-time data synchronization from scales, barcode scanners, sensors, and production machines through downloadable edge drivers and supported protocols.
The no-code visual editor enables operations teams to build and modify applications using drag-and-drop functionality without programming expertise. Native AI and ML capabilities are integrated throughout the platform, including automated PDF-to-app conversion and text prompts to dashboards. The system provides Open API for customization and integration with existing enterprise systems including ERP, MES, and third-party applications. Multi-device support includes mobile devices, computers, machines, and wearables, with mobile-responsive interfaces for flexible operator access. Real-time data analytics and production tracking operate across work orders and batches with AI-powered insights.
Pricing is undisclosed: no tiers, per-user costs, or annual licence fees appear on the vendor's website. Tulip operates on a subscription-based pricing model, marketed to pharmaceutical and life sciences manufacturers as an enterprise platform.
Custom quotes are available on request through a demo, based on organisational size, module selection (eBR, weigh & dispense, analytics, etc.), deployment scope, and number of production lines or facilities. The company states it targets rapid ROI ("see ROI in months, not years"). Trial options and detailed pricing are undisclosed beyond direct contact with Tulip's sales team at tulip.co.
Tulip's Composable MES for Pharma emphasizes rapid deployment with implementation timelines as short as 90 days using pre-built validated apps for logbooks, weigh & dispense, sampling, packaging, and eBR review. The platform is validated using Computer System Assurance (CSA) guidance, which the vendor states reduces validation overhead versus traditional approaches.
The no-code approach allows operations teams to create and adjust batch record applications directly using visual tools, minimizing dependency on IT resources and external consultants. Pre-qualified platform templates accelerate time-to-value, with customers reporting 75% reduction in time spent reviewing detailed logbooks and 30% faster processes. Case studies include Sharp Packaging, which achieved a 30% reduction in packaging time with real-time package verification capabilities. The composable architecture enables phased rollouts starting with high-priority modules and expanding to additional capabilities as organizations mature their digital transformation initiatives.
Anonymous feedback from pharmaceutical professionals using this solution
4.5 out of 5
Based on 36 verified reviews
What Users Like
Users highly value Tulip's ease of use and intuitive interface, finding it quick to learn for application development with drag-and-drop features enabling fast development and deployment. The high level of customization enhances app development tailored to specific manufacturing needs, with seamless API integration enabling real-time data connectivity with multiple software platforms. Customer support receives consistent praise for being friendly, knowledgeable, and providing prompt, effective solutions to issues. Users appreciate the app-creation capabilities that let operations teams build solutions without extensive programming knowledge, including process engineers and quality personnel configuring batch records and logbooks directly.
What Users Dislike
Users report limited functionality in reporting and analytics capabilities, with basic analytics tools considered insufficient for advanced data analysis tasks. Connectivity issues occasionally arise, with users struggling to identify causes of latency and service disruptions. Server instability is cited as problematic, causing confusion over connection issues and operational glitches that disrupt production workflows. The complexity of advanced reporting features requires proper training and documentation, leading to adaptation time for new users. Without sufficient training and simplified documentation, users find the platform's usability challenging for more complex configurations. Some users note that while the core app-building is simple, advanced customizations may still require technical expertise.
Help the community
Share your experience with Tulip Electronic Batch Records anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section